RT Journal Article
SR Electronic
T1 International expansion of a novel SARS-CoV-2 mutant
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.15.20035204
DO 10.1101/2020.03.15.20035204
A1 Wang, Minjin
A1 Li, Mengjiao
A1 Ren, Ruotong
A1 Bråve, Andreas
A1 van der Werf, Sylvie
A1 Chen, En-Qiang
A1 Zong, Zhiyong
A1 Li, Weimin
A1 Ying, Binwu
YR 2020
UL http://medrxiv.org/content/early/2020/03/17/2020.03.15.20035204.abstract
AB Letter to the editor. There is no abstract. The summary was showed: SARS-CoV-2 has inevitably mutated during its pandemic spread to cause unpredictable effects on COVID-19 and complicate epidemic control efforts. Here we report that a novel SARS-CoV-2 mutation (ORF3a) appears to be spreading worldwide, which deserves close attention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Science & Technology Department of Sichuan Province (Grant number: 2020YFS0004) and West China Hospital of Sichuan University (Grant number: HX-2019-nCoV-066).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe published genome data are abtained from the GISAID EpiFluTM database and NGDC database. https://www.gisaid.org/ https://bigd.big.ac.cn/ncov